ImmunityBio, Inc. (IBRX)
9.91
-0.21
(-2.08%)
USD |
NASDAQ |
Oct 13, 14:04
ImmunityBio Total Return Level : 10.12 for Oct. 12, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 12, 2026 | 10.12 |
| October 09, 2026 | 10.51 |
| October 08, 2026 | 9.91 |
| October 07, 2026 | 9.75 |
| October 06, 2026 | 9.69 |
| October 05, 2026 | 10.38 |
| October 02, 2026 | 10.28 |
| October 01, 2026 | 9.28 |
| September 30, 2026 | 9.44 |
| September 29, 2026 | 8.83 |
| September 28, 2026 | 8.52 |
| September 25, 2026 | 8.44 |
| September 24, 2026 | 8.64 |
| September 23, 2026 | 8.63 |
| September 22, 2026 | 9.29 |
| September 21, 2026 | 8.45 |
| September 18, 2026 | 8.48 |
| September 17, 2026 | 8.46 |
| September 16, 2026 | 7.91 |
| September 15, 2026 | 8.14 |
| September 14, 2026 | 8.37 |
| September 11, 2026 | 7.91 |
| September 10, 2026 | 7.72 |
| September 09, 2026 | 8.06 |
| September 08, 2026 | 8.29 |
| Date | Value |
|---|---|
| September 04, 2026 | 8.08 |
| September 03, 2026 | 8.19 |
| September 02, 2026 | 7.95 |
| September 01, 2026 | 7.87 |
| August 31, 2026 | 7.95 |
| August 28, 2026 | 8.05 |
| August 27, 2026 | 8.40 |
| August 26, 2026 | 8.25 |
| August 25, 2026 | 8.19 |
| August 24, 2026 | 7.58 |
| August 21, 2026 | 7.79 |
| August 20, 2026 | 7.84 |
| August 19, 2026 | 8.13 |
| August 18, 2026 | 7.72 |
| August 17, 2026 | 7.92 |
| August 14, 2026 | 7.57 |
| August 13, 2026 | 7.65 |
| August 12, 2026 | 7.74 |
| August 11, 2026 | 7.60 |
| August 10, 2026 | 7.49 |
| August 07, 2026 | 7.64 |
| August 06, 2026 | 7.32 |
| August 05, 2026 | 7.25 |
| August 04, 2026 | 6.95 |
| August 03, 2026 | 7.15 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Moderna, Inc. | 213.74 |
| Sarepta Therapeutics, Inc. | 17.44 |
| Arrowhead Pharmaceuticals, Inc. | 60.73 |
| Oncolytics Biotech, Inc. | 0.4733 |
| Sangamo Therapeutics, Inc. | 0.15 |